Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03355872
What this trial is testing

A Randomised, Double-blind, Phase I/II Study to Evaluate the PK, PD, Safety, and Efficacy Between HLX01 and Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Treatment With DMARDs

Who this might be right for
Rheumatoid Arthritis
Shanghai Henlius Biotech 194
Early research (Phase 1)Study completedNCT02835235
What this trial is testing

A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity

Who this might be right for
Metabolism and Nutrition DisorderObesity
Novo Nordisk A/S 48
Testing effectiveness (Phase 2)Study completedNCT00664716
What this trial is testing

Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) Participants

Who this might be right for
Rheumatoid Arthritis
Biogen 391
Early research (Phase 1)Not Yet RecruitingNCT07462455
What this trial is testing

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
Xiamen Amoytop Biotech Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03663335
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 418
Not applicableNot Yet RecruitingNCT07815938
What this trial is testing

Immune Monitoring-Guided Individualized Tacrolimus Therapy in Renal Transplant Recipients: An Observational Study and PK/PD Modeling

Who this might be right for
Transplant Recipient (Kidney)
Zhongnan Hospital 50
Testing effectiveness (Phase 2)Study completedNCT05843578
What this trial is testing

STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

Who this might be right for
Fibrostenotic Crohn's Disease
Agomab Spain S.L.U. 103
Testing effectiveness (Phase 2)Looking for participantsNCT06343792
What this trial is testing

Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease

Who this might be right for
Steroid Refractory GVHD
ReAlta Life Sciences, Inc. 66
Early research (Phase 1)Study completedNCT05723692
What this trial is testing

A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
AltruBio Inc. 56
Early research (Phase 1)Study completedNCT03325595
What this trial is testing

Single Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117

Who this might be right for
Healthy Volunteers
Aelis Farma 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05644561
What this trial is testing

Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisgMG
Alexion Pharmaceuticals, Inc. 12
Early research (Phase 1)Study completedNCT01765478
What this trial is testing

Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers

Who this might be right for
Rheumatoid Arthritis
Hanmi Pharmaceutical Company Limited 62
Early research (Phase 1)WithdrawnNCT05607589
What this trial is testing

The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects

Who this might be right for
Healthy
Daewoong Pharmaceutical Co. LTD.
Early research (Phase 1)Study completedNCT00345189
What this trial is testing

Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors

Who this might be right for
TumorsLymphoma
Biogen 70
Early research (Phase 1)Study completedNCT01462617
What this trial is testing

Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557

Who this might be right for
Asthma
GlaxoSmithKline 61
Not applicableUnknownNCT03787550
What this trial is testing

PK/PD of the Sedatives, Analgesics and Antibiotics in Patients Receiving ECMO

Who this might be right for
Drug Effect
Guangdong Provincial People's Hospital 36
Early research (Phase 1)Study completedNCT06308874
What this trial is testing

Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females

Who this might be right for
Non-alcoholic Steatohepatitis
J2H Biotech 16
Early research (Phase 1)Study completedNCT03445013
What this trial is testing

A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis

Who this might be right for
Psoriasis
Novan, Inc. 36
Early research (Phase 1)Study completedNCT02403713
What this trial is testing

A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers

Who this might be right for
Asthma
Mundipharma Research Limited 125
Testing effectiveness (Phase 2)Looking for participantsNCT06249919
What this trial is testing

A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients

Who this might be right for
Seneorineural DeafnessSudden Sensorineural Hearing Loss
Neuracle Science Co., LTD. 138
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation